Table 2.
WD patients | Cp (mg/dL) | Age (years) | No. of patients | |||||
---|---|---|---|---|---|---|---|---|
Total | 0–5 | 5–10 | 10–15 | 15–20 | ≥ 20 | |||
Asymptomatic WD | 5.5 ± 4.6a | 5.4 ± 2.3b | 261 | 157 | 67 | 22 | 9 | 6 |
Symptomatic WD | 7.0 ± 4.8 | 9.4 ± 2.6 | 56 | 27 | 11 | 14 | 4 | 0 |
WD w/o ALF | 5.6 ± 4.6c | 6.0 ± 2.8d | 302 | 180 | 75 | 30 | 11 | 6 |
WD w/ ALF | 9.3 ± 4.7 | 9.0 ± 2.2 | 15 | 4 | 3 | 6 | 2 | 0 |
Total | 5.7 ± 4.7 | 5.7 ± 4.7 | 317 | 184 | 78 | 36 | 13 | 6 |
WD, Wilson’s disease; ALF, acute liver failure
aRepresents comparison of serum ceruloplasmin in asymptomatic WD with symptomatic WD children, p value < 0.05
bRepresents comparison of age in asymptomatic WD with symptomatic WD children, p value < 0.001
cRepresents comparison of serum ceruloplasmin between WD children with and without acute liver failure, p value < 0.01
dRepresents comparison of age between WD children with and without acute liver failure, p value < 0.001